跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMLESSA TABLETS 8 MG/ 5MG - HSA Drug Approval Details
Approvals
/
HSA
/
AMLESSA TABLETS 8 MG/ 5MG
Approved
THERAPEUTIC
AMLESSA TABLETS 8 MG/ 5MG
KRKA, D.D., NOVO MESTO (SLOVENIA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 27, 2019
Approval ID
55e91ed5fe5dca28
Company
KRKA, D.D., NOVO MESTO (SLOVENIA)
Type
Therapeutic
Approval Details
Approval Id
55e91ed5fe5dca28
Drug Name
AMLESSA TABLETS 8 MG/ 5MG
Product Name
AMLESSA TABLETS 8 MG/ 5MG
Approval Number
SIN15727P
Approval Date
2019-06-27
Registrant
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C09BB04
Atc Item Name
perindopril and amlodipine
Pharma Manufacturer Name
SINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Active Ingredients
Perindopril 6.68 mg eqv. to Perindopril tert-Butylamine
8.000mg
Amlodipine besilate 6.935 mg eqv. to amlodipine
5.000mg
AMLODIPINE BESILATE 6.935 MG EQV. TO AMLODIPINE
5 MG
PERINDOPRIL 6.68 MG EQV. TO PERINDOPRIL TERT-BUTYLAMINE
8 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 27, 2019
Approval ID
55e91ed5fe5dca28
Type
Therapeutic
Back to HSA Approvals